Neuramis Deep
Composition:
HA – 20 mg/mL
Package:
a syringe with 1.0 ml
needle 27G 13mm UTW*
UTW – Ultra Thin Wall Needle
Ultra Thin Wall Needle has a larger inner diameter compared to regular needles.
It improves flow rates and lowers extraction force during the injection.
Indications of Neuramis Deep for use:
- Correction of moderate and deep wrinkles.
- Increased lip volume.
- Elasticity and tightening of the skin.
- Improved elasticity.
- Skin hydration.
Benefits of Neuramis Deep:
- The most comfortable procedure – lidocaine, part of Neuramis Deep Lidocaine, has an analgesic effect, making the procedure as comfortable as possible for patients.
- The high degree of purification – thanks to the unique SHAPE technology, characterized by a 2-stage cross-linking process and an increased function of hyaluronic acid purification, Neuramis Deep Lidocaine is a reliable and effective product.
- Ideal for correcting deep wrinkles and restoring lost volume.
- Fast and safe result – the effect of Neuramis Deep Lidocaine is noticeable immediately after the procedure, and a significant improvement in the structure and elasticity of the skin is achieved, as well as the replenishment of the lost volume.
- Easy to use – ultra-thin needles manufactured by the Japanese company TSK Laboratory and the plasticity of hyaluronic acid guarantee ease of use and natural shapes.
- Top quality – Neuramis Deep Lidocaine uses hyaluronic acid supplied by a Japanese company (Shiseido), the safety of which has been confirmed by the US Food and Drug Administration (FDA) and the European Administration for Quality Assurance of Medical Services and Medicines …
- Long-term effect – the duration is up to 12 months, depending on the patient’s characteristics.
Neuramis Series – Find the Right Filler for You
Neuramis Volume Lidocaine – Best for facial contouring & volume restoration
Neuramis Deep Lidocaine – Ideal for deep wrinkles & lost volume correction
Neuramis Light Lidocaine – Perfect for skin hydration & fine lines
Reviews
There are no reviews yet.